Endocrinology

Obesity

Finding

Obesity

Disease

Obesity hypoventilation syndrome

Disease

OCEAN(a)-DOSE (olpasiran 10 mg)

Study

OCEAN(a)-DOSE (olpasiran 225 mg every 12 weeks)

Study

OCEAN(a)-DOSE (olpasiran 225 mg every 24 weeks)

Study

OCEAN(a)-DOSE (olpasiran 75 mg)

Study

Octreotide

Drug

Octreotide DR

Drug

ODYSSEY

Study

Olezarsen

Drug

OLV in Thoracic Anesthesia

Study

ONTARGET (telmisartan with ramipril)

Study

ONTARGET (telmisartan)

Study

ONWARDS 1

Study

ONWARDS 3

Study

OPTIMISE II

Study

Oral GLP-1 (danuglipron 120 mg)

Study

Oral GLP-1 (danuglipron 40 mg)

Study

ORIGIN n-3 Fatty Acids

Study

ORION-10

Study

ORION-11

Study

Osmolality, increased

Finding

Osteoporosis in men

Disease

Ovarian hyperstimulation syndrome

Disease